Physicochemical and preclinical pharmacokinetic and toxicological evaluation of LK-423—a new phthalimido-desmuramyl-dipeptide derivative with immunomodulating activity-Reference-Cited by-同舟云学术

Physicochemical and preclinical pharmacokinetic and toxicological evaluation of LK-423—a new phthalimido-desmuramyl-dipeptide derivative with immunomodulating activity

Published:2009-10-16 Issue:11 Volume:35 Page:1293-1304
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Smrdel Polona,Grabnar Iztok,Locatelli Igor,Černe Manica,Andrenšek Samo,Kovačič Nataša,Kristl Albin,Bogataj Marija,Urleb Uroš,Mrhar Aleš

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

http://www.tandfonline.com/doi/pdf/10.3109/03639040902889814

Reference24 articles.

1. Kuby J. (1994). Immunology. 2nd ed. New York: Freeman H.W. Co, 297–322.

2. Interleukin-10 Therapy—Review of a New Approach

3. Interleukin-10 and the Interleukin-10 Receptor

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency;ACS Medicinal Chemistry Letters;2022-07-18

2. Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity;Journal of Medicinal Chemistry;2021-05-27

3. Design, synthesis and biological evaluation of immunostimulating mannosylated desmuramyl peptides;Beilstein Journal of Organic Chemistry;2019-07-29

4. Advances in Desmuramyl Peptide Research;Croatica chemica acta;2019

5. Discovery of Nanomolar Desmuramylpeptide Agonists of the Innate Immune Receptor Nucleotide-Binding Oligomerization Domain-Containing Protein 2 (NOD2) Possessing Immunostimulatory Properties;Journal of Medicinal Chemistry;2018-03-15